A Triple Rare E709K and L833V/H835LEGFRMutation Responsive to an Irreversible Pan‐HER Inhibitor: A Case Report of Lung Adenocarcinoma Treated with Afatinib. Issue 5 (May 2016) - Frega, Stefano; Conte, PierFranco; Fassan, Matteo; Polo, Valentina; Pasello, Giulia